Evidence map›Paper›PMID 19557154›Full record

ReviewPLoS pathogens2009

Efflux in fungi: la pièce de résistance.

Jeffrey J Coleman, Eleftherios Mylonakis

Open access · goldAbstract readReview
In one paragraph

Review in PLoS pathogens, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 124 papers.

0numbers the graph read from it
0cells of the map it votes in
124citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

124 citing papers in PubMed, 229 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Decoding theJournal of agricultural and food chemistry · 2025
    Article
  6. Rise and Fall ofJournal of fungi (Basel, Switzerland) · 2025
    Article
  7. Article
  8. Article
  9. The Antimicrobial Resistance ofJournal of fungi (Basel, Switzerland) · 2025
    Article
  10. Review
  11. Article
  12. Mycology · 2025
    Article
  13. Article
  14. Review
  15. Article
  16. Two promisingFrontiers in pharmacology · 2024
    Article
  17. Article
  18. Article
  19. Effects of biocontrolFEMS microbes · 2024
    Article
  20. Article

64 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Jeffrey J ColemanDivision of Infectious Diseases, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.
Eleftherios Mylonakis
Harvard University · USMassachusetts General Hospital · US

Funding

INFECTIOUS DISEASE AND BASIC MICROBIOLOGICAL MECHANISMST32AI007061 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Marcia B Goldberg · 1985 to 2026
$12.1M
A C.elegans high-throughput assay for the identification of new antifungal agentsR01AI075286 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI MYLONAKIS, ELEFTHERIOS · 2008 to 2010
$1.3M
NIAID NIH HHS R01 AI075286NIAID NIH HHS T32 AI007061
6 · The paper itself

Abstract

Pathogens must be able to overcome both host defenses and antimicrobial treatment in order to successfully infect and maintain colonization of the host. One way fungi accomplish this feat and overcome intercellular toxin accumulation is efflux pumps, in particular ATP-binding cassette transporters and transporters of the major facilitator superfamily. Members of these two superfamilies remove many toxic compounds by coupling transport with ATP hydrolysis or a proton gradient, respectively. Fungal genomes encode a plethora of members of these families of transporters compared to other organisms. In this review we discuss the role these two fungal superfamilies of transporters play in virulence and resistance to antifungal agents. These efflux transporters are responsible not only for export of compounds involved in pathogenesis such as secondary metabolites, but also export of host-derived antimicrobial compounds. In addition, we examine the current knowledge of these transporters in resistance of pathogens to clinically relevant antifungal agents.

Indexed as

Drug Resistance, Multiple, FungalFungal ProteinsFungiGenome, FungalMembrane Transport ProteinsMycosesPlant DiseasesVirulenceFungal ProteinsMembrane Transport Proteins

Identifiers

PMID19557154
PMCPMC2695561
OpenAlexW2066624240

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.